FDA Grants Approval for Gallium Ga-68 Gozetotide (ANDA216410)
The FDA has granted approval for the ANDA216410 application for Gallium Ga-68 Gozetotide submitted by Radiomedix.
Asset / Drug
Drug and asset intelligence for Radiomedix with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.